A clinical trial to study the levels of vascular endothelial growth factor in the fluid in the front part of the eye in cases of occlusion of venous supply of the eye and to correlate with the clinical features and nerve thickness as obtained by scanning and nerve function tests
Phase 3
- Conditions
- Health Condition 1: null- central retinal vein occlusion
- Registration Number
- CTRI/2012/12/003270
- Lead Sponsor
- arayana Nethralaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Inclusion Criteria
•Patients with central retinal vein occlusion who are treatment naïve with or without visual loss < 3 months duration with or without glaucoma
•Patients with well controlled DM will be included when the other eye has less than severe non proliferative diabetic retinopathy
Exclusion Criteria
Exclusion Criteria
•Ocular intervention within 3 months like intra ocular surgery, intravitreal steroid/anti VEGF injections and previous history of retinal laser treatment.
•Neovascular glaucoma
•IOP > 21 mmHg
•Ocular inflammatory conditions
•Age related macular degeneration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method